Skip to Main Content

Joseph E. Sullivan

MD

Director, Pediatric Epilepsy Center
Pediatric neurologist
Lover of backpacking, skiing and family dinners

Dr. Joseph Sullivan, a pediatric neurologist, serves as director of the UCSF Pediatric Epilepsy Center, where he specializes in evaluating and caring for children with epilepsy, particularly refractory epilepsy (in which medications fail to control seizures). He has special interests in Dravet syndrome and PCDH19-related epilepsy (two genetic forms of the condition) as well as in evaluating children for epilepsy surgery.

Sullivan earned his medical degree at Albany Medical College. He completed a residency in pediatrics and served an additional year as chief resident at Ann & Robert H. Lurie Children's Hospital of Chicago, part of Northwestern Medicine. At Children's Hospital of Philadelphia, he completed a residency in child neurology and a fellowship in epilepsy and clinical neurophysiology. He joined the UCSF faculty in 2007.

Sullivan is a member of the American Epilepsy Society and serves on boards for several organizations. His roles include chair of the PCDH19 Alliance's scientific advisory board, member of the Epilepsy Foundation of Northern California's board of directors, and member of the Dravet Syndrome Foundation's medical advisory board and board of directors.

  • Education

    Albany Medical College, MD, 1998

  • Residencies

    Children's Memorial Hospital, Northwestern University, Pediatrics, 2002

    University of Pennsylvania Hospital, Children's Hospital of Philadelphia, Child Neurology, 2005

  • Fellowships

    Children's Hospital of Philadelphia, Clinical Neurophysiology and Epilepsy, 2007

  • Board Certifications

    Neurology - Child Neurology, American Board of Psychiatry and Neurology.

    Epilepsy, American Board of Psychiatry and Neurology.

  • Academic Title

    Professor

The heartbreaking toll seizures take on children and families drives me to provide innovative treatments and support for the entire family.

Where I see patients (1)

    Decorative Caduceus

    A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN...

    Recruiting

    More about this study
    Decorative Caduceus

    Assessment of Safety of the Use of Fenfluramine in Children with Dravet Syndrome Under 24 Month...

    A description of the percentage of participants that have at least one adverse event.

    Recruiting

    More about this study
    Decorative Caduceus

    A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lenn...

    An Adverse Event (AE) is defined as any untoward medical occurrence in a clinical investigation participant administered a drug; it does not necessarily have to have a causal relationship with this treatment. An AE can therefore b...

    Recruiting

    More about this study
    See all clinical trials

    Tender wagging care

    Our therapy dogs spread joy and smiles at the bedside and throughout the hospital.

    Visit Child Life services

    Share